Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tizaspray versus Sirdalud in acute low back pain
2014-003040-12Phase 3Completed
- Sponsor
- MDM Pharma
- Start
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of Tizaspray in acute lumbago (2 arms), sponsored by MDM Pharma. Primary endpoints: Hand-to-floor distance at day 8, Low Back Pain Intensity Scale up to 7 days and 1 more. Started Jul 2014; status: completed.
02
Drugs
Tizaspray
03
Conditions
acute lumbago
Beyond the preview
Go deeper on 2014-003040-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-003040-12.